All muscular dystrophies cause muscle weakness, but life expectancy can vary dramatically between types of muscular dystrophy.
Ractigen Therapeutics Co. Ltd.’s small activating RNA (saRNA) therapeutic, RAG-18, has been awarded U.S. orphan drug designation for the treatment of Duchenne muscular dystrophy (DMD) and Becker ...
Muscular dystrophy is a group of inherited conditions that lead to progressive weakening of voluntary muscles and, in some cases, impact the heart and other organs. There are nine major types of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results